Quantessence Capital’s Confluent CFLT Stock Holding History

Quantessence Capital’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,337	Closed	-$345K	–	352
2024 Q4	$345K	Buy	+12,337	New	+$331K	0.14%	156

Other funds holding CFLT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantessence Capital's CFLT Position: Q1 2025 in Review

Quantessence Capital sold out of Confluent (CFLT) in Q1 2025, closing a stake of 12,337 shares — an estimated $345K sold.

Quantessence Capital first reported a position in CFLT in Q4 2024 and held it in 1 quarter. The position peaked at $345K in Q4 2024. 400 funds tracked by Wall St. Rank hold CFLT as of Q1 2025.

Quantessence Capital reported no remaining Confluent position as of Q1 2025 after selling out during the quarter.
Quantessence Capital sold 12,337 Confluent shares in Q1 2025, an estimated $345K.
Quantessence Capital first reported a position in Confluent in Q4 2024 and held it in 1 quarter.
Quantessence Capital's Confluent position peaked at $345K in Q4 2024.
400 funds tracked by Wall St. Rank held Confluent as of Q1 2025.

Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.